Key points
- In a meta-analysis of 21 studies, 22% of people who used cannabis had a cannabis use disorder. In young people with weekly or daily use, the risk of dependence was 33%.
- Early onset of use, frequent use, tobacco smoking and other mental illnesses or addictions are associated with a higher risk.
- In a meta-analysis, withdrawal symptoms such as irritability, sleep disturbances and restlessness occurred in just under half of people with regular use.
- There are few data on medically supervised therapies. A randomised study from the USA without medical dose management found more symptoms of dependence.
Cannabis can be addictive, but not everyone who uses it becomes dependent. In a meta-analysis of 21 studies, 22% of people who used cannabis had a cannabis use disorder, and 13% met the criteria for dependence. In young people with weekly or daily use, the risk of dependence was 33%.1
These figures come almost exclusively from studies on recreational use. There are considerably fewer data on therapies prescribed and supervised by doctors. The risk there is not zero, but it can be monitored and assessed with an assessment and regular check-ups. This article summarises what is known.
Dependence, use disorder, habituation: the terms
Today, experts usually speak of a cannabis use disorder. This means a pattern of use that continues despite disadvantages: for example, when someone uses more than planned, tries unsuccessfully to stop, neglects obligations or spends a lot of time obtaining cannabis and recovering. Dependence is the more pronounced form. The meta-analysis by Leung and colleagues distinguished between the two diagnoses according to the usual classifications.1
Two physical processes must be distinguished from this. Tolerance means that, with regular intake, the same amount has a weaker effect. Withdrawal symptoms are complaints that occur after stopping, including after a medically supervised end of therapy. Both are considered an indication of a use disorder but do not prove it on their own. Many other medicines, such as opioids or benzodiazepines, also lead to tolerance without every patient becoming dependent.3
How high is the risk of cannabis dependence? The figures
The most important figures at a glance:
| Study | Group | Result |
|---|---|---|
| Leung 2020, 21 studies | people who use cannabis | 22% use disorder, 13% dependence |
| Leung 2020, cohort studies | young people, weekly or daily | 33% dependence |
| Lopez-Quintero 2011, USA | people who use cannabis, lifetime | 8.9% dependence |
The Leung meta-analysis included studies from 2009 to 2019. The ranges were wide: for use disorder, the confidence interval was between 18 and 26%. For people with regular use, cohort data on use disorder in the broader sense were lacking.1
A large US survey of 7,389 people who had ever used cannabis estimated the probability of developing dependence over a lifetime at 8.9%. For comparison: for nicotine it was 67.5%, for alcohol 22.7%. Half of the cases of cannabis dependence occurred within about five years of starting use, that is, faster than with nicotine or alcohol.2
The figures differ because of different definitions, time periods and groups. What all the studies have in common: some people who use cannabis develop dependence, and the risk increases with frequency.
Risk factors for cannabis dependence
The 2017 report of the US National Academies summarised research on problematic use. Among the factors associated with a higher risk, it names early onset of use, frequent use, male sex and tobacco smoking.5
Further findings from the studies above:
- Age at onset: Leung and colleagues emphasise the higher risk in people who start early and use frequently in adolescence.1
- Other mental illnesses and addictions: In the US survey, the risk of dependence was increased in people with psychiatric comorbidities or other dependences.2
- Frequency: In the withdrawal meta-analysis, daily use was associated with more frequent withdrawal symptoms.3
A past or current addiction is therefore something your doctor must know about before therapy. How pre-existing mental illnesses are handled is described in the article Cannabis medicine despite a pre-existing mental illness.
Tolerance and withdrawal with cannabis
A meta-analysis of 47 studies with 23,518 participants examined withdrawal symptoms in people with regular or dependent use. Overall, 47% had a withdrawal syndrome. In samples from the general population it was 17%, in people treated as outpatients 54% and in those treated as inpatients 87%. Daily use and tobacco and other substance use disorders were associated with more withdrawal symptoms.3
Typically described are irritability, restlessness, sleep disturbances and vivid dreams, reduced appetite and low mood. The symptoms are usually unpleasant but not life-threatening. The authors recommend that professionals prepare and support people who reduce their use.3
During therapy, tolerance can cause the effect to diminish. Whether the dose is then adjusted, a break is taken or the therapy is ended is decided by the doctor in the individual case.
Medical use and recreational use: what can be compared
Studies on recreational use can only be transferred to medical therapy to a limited extent. In recreational use, people choose the product, amount and frequency themselves, often start young and smoke cannabis together with tobacco. With a medical prescription, the indication, preparation and dose are fixed, and there are follow-up check-ups.
A randomised study from the Boston area shows, however, that “medical” alone does not protect against a use disorder. 186 adults with pain, sleep disorders, anxiety or depressive symptoms were allowed to obtain a “medical marijuana card” either immediately or only after twelve weeks. Participants chose the product, dose and frequency themselves at dispensaries. In the group with immediate access, 17.1% developed a use disorder, compared with 8.6% in the control group. The risk was particularly increased in people with anxiety or depressive symptoms. Pain, anxiety and depressive symptoms did not improve significantly; sleep complaints were rated as less severe.4
The study setting does not correspond to medically dosed therapy with check-ups, as provided for in Switzerland. Comparable studies for such a setting are, however, lacking. To be honest, then: the risk of dependence with medical use is not well quantified.
Recognising warning signs of dependence
The following signs are a reason to talk to your doctor:
- You take more or more often than prescribed, or the medicine does not last until the next prescription.
- You take it mainly because of your mood or to switch off, not because of the symptoms being treated.
- You have tried to take less and have not managed it.
- Without the medicine you become restless or irritable, or sleep badly.
- Work, family or leisure suffer because of your use.
In simplified form, these points correspond to the criteria that studies use to identify a use disorder.1,3
In Switzerland, according to the 2022 Swiss Health Survey, about 4% of 15- to 64-year-olds had used cannabis in the last 30 days. Cannabis is the most commonly used illegal substance in the country.6 If you have questions about your own use, SafeZone.ch, a platform run by the FOPH and Infodrog, offers free and anonymous online counselling.7 Other undesirable effects are described in the article Side effects of cannabis.
How it works at evidena
Whether cannabis therapy is an option for you is decided by the doctor after an assessment. Mention any past or current addictions, including to alcohol, nicotine or medicines, as well as your previous cannabis use. If a prescription is issued, it must be filled at a pharmacy within one month. As a rule, the prescribed quantity covers one month, in justified cases at most three months of treatment.8 At each follow-up prescription, the course of treatment is discussed, including tolerance and warning signs. You can book appointments at https://portal.evidena.care/appointments, and we answer questions via WhatsApp or at info@evidena.care. How the therapy is structured is shown on the page How it works.
Conclusion
Cannabis can be addictive. In studies on recreational use, depending on the definition, this affected around one in eight to one in five people who used it, and considerably more in young people with frequent use. Good figures for medically supervised therapies are lacking. An open history, honest feedback and regular check-ups are therefore the most important protection.
Frequently asked questions
How many people become dependent on cannabis?
In a meta-analysis, 13% of people who used cannabis had dependence and 22% had a cannabis use disorder in the broader sense. In young people with regular use, the proportion was considerably higher.
Is medical cannabis addictive?
Dependence is also possible with medical use. How common it is with medically managed therapy has been little studied; regular check-ups help to recognise warning signs early.
What withdrawal symptoms are there with cannabis?
Those described include irritability, restlessness, sleep problems, reduced appetite and low mood. They occur mainly after regular, longer-term use.
May I simply stop a cannabis medicine?
Discuss any change to or end of therapy with your doctor beforehand. This makes it easier to assess withdrawal symptoms and a return of symptoms.
Where can I find help with addiction issues in Switzerland?
SafeZone.ch offers free and anonymous online counselling on addiction issues. Your GP and cantonal addiction services are also points of contact.
Sources
- Leung J et al. What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav. 2020;109:106479. doi:10.1016/j.addbeh.2020.106479
- Lopez-Quintero C et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the NESARC. Drug Alcohol Depend. 2011;115(1-2):120-130. doi:10.1016/j.drugalcdep.2010.11.004
- Bahji A et al. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(4):e202370. doi:10.1001/jamanetworkopen.2020.2370
- Gilman JM et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e222106. doi:10.1001/jamanetworkopen.2022.2106
- National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington DC: National Academies Press; 2017. doi:10.17226/24625
- Sucht Schweiz, Zahlen und Fakten: Cannabis (accessed 13 November 2026)
- SafeZone.ch, Online-Suchtberatung von BAG und Infodrog (accessed 13 November 2026)
- Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 47, Stand am 23. Januar 2023, Fedlex (accessed 13 November 2026)